Pharmaceutical company Pfizer has awarded the creative accounts for four of its brands to Bates Worldwide in New York.

The four are Bonine (motion-sickness medicine), Desitin (diaper-rash treatment), Zantac (heartburn drug) and Rolaids (antacid). Combined billings are estimated at $40–50 million.

Explaining the selection, Pfizer said it wanted to “better balance” the accounts between its two main agencies Bates and J Walter Thompson in New York. It added that the move was recognition of “the quality work” done by Bates for Pfizer brands such as Benadryl and Sudafed.

News source: New York Times